Further investigation of other transcripts in the pan-drug signature reveal that most have a known tumor suppressive function but others such as PRDM1 [31, 32], SESN1/2 [33, 34] may play a complicated or multiplex role in CRC and other cancers. Here, PRDM1 is linked to neoplasm.